NasdaqCM - Nasdaq Real Time Price USD
Evaxion A/S (EVAX)
3.0951
+0.0851
+(2.87%)
As of 12:25:52 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
--
-12,940
-17,691
-25,774
-21,933
Investing Cash Flow
--
-3
-93
-268
-1,330
Financing Cash Flow
--
13,129
10,691
7,853
49,805
End Cash Position
--
5,952
5,583
13,184
32,166
Capital Expenditure
--
--
-87
-292
-1,360
Issuance of Capital Stock
--
16,550
9,168
428
53,854
Issuance of Debt
--
0
65
7,849
0
Repayment of Debt
--
-1,136
-697
-424
-289
Free Cash Flow
--
-12,940
-17,778
-26,066
-23,293
12/31/2021 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GUBRA.CO Gubra A/S
540.00
+13.92%
BAVA.CO Bavarian Nordic A/S
188.00
+3.90%
PHIO Phio Pharmaceuticals Corp.
2.3816
-14.59%
IOBT IO Biotech, Inc.
1.4950
-3.55%
RENB Renovaro Inc.
0.4045
+12.27%
ZEAL.CO Zealand Pharma A/S
497.00
+4.32%
ZVSA ZyVersa Therapeutics, Inc.
0.7075
+10.58%
RNXT RenovoRx, Inc.
1.3700
0.00%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
22.40
+3.23%
GMAB.CO Genmab A/S
1,495.00
+3.42%